4//SEC Filing
WORTZMAN MARILYN E 4
Accession 0001181431-12-018613
CIK 0001178711other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:08 PM ET
Size
18.0 KB
Accession
0001181431-12-018613
Insider Transaction Report
Form 4
WORTZMAN MARILYN E
VP, Finance
Transactions
- Sale
Common Stock
2012-03-19$10.00/sh−4,027$40,270→ 217 total - Sale
Common Stock
2012-03-19$10.00/sh−4,600$46,000→ 217 total - Sale
Common Stock
2012-03-19$10.00/sh−573$5,730→ 217 total - Exercise/Conversion
Common Stock
2012-03-19$1.77/sh+4,027$7,123→ 4,244 total - Exercise/Conversion
Common Stock
2012-03-19$2.12/sh+573$1,216→ 790 total - Exercise/Conversion
Common Stock
2012-03-19$4.14/sh+4,600$19,044→ 4,817 total - Exercise/Conversion
Employee Stock Option (right to buy)
2012-03-19−4,027→ 0 totalExercise: $1.77Exp: 2017-04-04→ Common Stock (4,027 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2012-03-19−573→ 5,081 totalExercise: $2.12Exp: 2017-08-22→ Common Stock (573 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2012-03-19−4,600→ 15,400 totalExercise: $4.14Exp: 2019-02-12→ Common Stock (4,600 underlying)
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 17, 2011.
- [F2]One-fourth of the shares subject to the option vested on March 16, 2008 and one forty-eighth of the shares shall vest monthly thereafter.
- [F3]One-fourth of the shares subject to the option vested on August 22, 2008 and one forty-eighth of the shares shall vest monthly thereafter.
- [F4]The option vests in forty-eight equal monthly installments beginning March 12, 2009.
Documents
Issuer
Transcept Pharmaceuticals Inc
CIK 0001178711
Entity typeother
Related Parties
1- filerCIK 0001235962
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:08 PM ET
- Size
- 18.0 KB